Pediatrics advances in 2024: choices in allergy, cardiology, critical care, endocrinology, gastroenterology, immunology, infectious diseases, neonatology, nephrology, neurology, nutrition, palliative care respiratory tract illnesses, and social media Authors: Carlo Caffarelli, Elena Bozzola, Ettore Piro, Bertrand Tchana, Enrico Vito Buono, Daniela Cunico, Sergio Bernasconi, Giovanni Corsello Published: 2025 ABSTRACT Over the past year, there have been several developments in various fields of pediatric medicine. This review features essential publications that have been published in the Italian Journal of Pediatrics in 2024. Papers have been selected in the areas of allergy, cardiology, critical care, endocrinology, gastroenterology, immunology, infectious diseases, neonatology, nephrology, neurology, nutrition, palliative care, respiratory tract illnesses, and social media. The findings have been examined to identify opportunities for improving the management of the diseases. Background In 2024, the Italian Journal of Pediatrics released numerous articles that could play a key role in major developments across many diseases. In this review we have highlighted key information derived from the most cited and most downloaded articles to maximize objectivity in recognizing the most impactful publications. The chosen articles point out progress made in different fields including allergy, cardiology, critical care, endocrinology, gastroenterology, immunology, infectious diseases, neonatology, nephrology, neurology, nutrition, palliative care, respiratory tract illnesses, and social media. Innovative and important advances in risk factors, disease mechanisms, diagnostic tools, and treatments, which can have may have a substantial short-term or over time effect on strategies for childhood illnesses have been underscored. Allergy and clinical immunology. 1- Drug hypersensitivity reactions; 2- Food anaphylaxis; 3- Asthma and altitude; 4- Short-acting β2-agonists in asthma attack; 5- Hymenoptera venom allergy; 6- Activated phosphoinositde 3-kinase syndrome Drug hypersensitivity reactions Drug hypersensitivity reactions in children pose a major clinical and public health challenge, marked by both under-recognition of true allergies and frequent over-diagnosis [1]. A recent retrospective study underscores these concerns, showing that while 8% of children referred to the tertiary care center are labelled as drug-allergic based on clinical history, confirmatory testing reveals true hypersensitivity in only a small fraction of cases, highlighting the frequent overestimation of drug allergies in pediatric practice [2, 3]. This overestimation underscores the importance of accurately identifying risk factors for drug hypersensitivity reactions in children, as emphasized by Mori et al. Contributing factors include age, sex, prior drug reactions, impaired metabolism, chronic conditions, polypharmacy, dosage, and route of administration. Viral infections may act as cofactors, and reactions can occur even in children without clear risk indicators, underscoring the need for clinical vigilance [4]. The significance of these findings is further reinforced by evidence showing that viral infections can mimic drug hypersensitivity, especially when antibiotics are co-administered. So, children with polypharmacy need careful evaluation, even without clear risk factors [5]. Food anaphylaxis Although infrequent, the risk of death from food-induced anaphylactic reactions remains a significant concern in children, with deep emotional and societal repercussions. In this context, Novembre et al. [6] provide a comprehensive overview of the epidemiology, triggers, and risk factors of fatal food-induced anaphylaxis. Their findings reveal a disproportionate burden in children and adolescents, with cow’s milk identified as the leading cause of fatal reactions in pediatric cases. This is consistent with other study [7] reporting milk and peanuts as the most frequent triggers of fatal and near-fatal events, especially in children with asthma. Among risk factors, there is the possibility of food allergy to be undiagnosed and the severity to be underestimated. Hence, an accurate diagnosis using skin testing [8], serum specific IgE detection and food challenge tests [9] is crucial. Turner et al. [10] underscored the unpredictability of severe reactions, demonstrating that common clinical risk markers, such as asthma or prior anaphylaxis, have limited prognostic value. So, it should be emphasized the importance of prompt epinephrine administration and the implementation of structured, allergen-specific management strategies, particularly for high-risk pediatric patients. Asthma and altitude Asthma is a common chronic respiratory disease in children, significantly influenced by environmental factors such as altitude. Bisoffi et al. [11] report that living at higher altitudes is associated with lower pediatric asthma prevalence and reduced airway inflammation, likely due to decreased exposure to allergens, pollution, and specific climatic conditions. However, some studies in their review indicate an increased risk of hospitalization at high altitude, possibly due to hypobaric hypoxia, colder and drier air, and elevated ozone levels. Ecological data are consistent with this, showing asthma rates remain stable below ∼ 1500 m but decrease progressively above that altitude [12]. Quignon et al. [13] confirmed these relationships, demonstrating improved asthma control, reduced FeNO levels [14], and better quality of life in 67 children with severe asthma following a stay at high altitude, with deterioration upon return home. Short-acting β2-agonists in asthma attack A critical review [15] underscores that in asthma exacerbations, inhaled short-acting β2-agonists (SABA) remains the first option for acute relief, with possible addition of inhaled ipratropium in moderate to severe attacks. In mild persistent asthma (ages 6–11 and adolescents), reliance on SABA monotherapy is discouraged. As-needed inhaled corticosteroids plus formoterol or salbutamol are preferred to better prevent exacerbations. Overuse of SABAs (> 3 canisters/year) correlates with elevated risks of exacerbations, emergency department visits, and even mortality, as demonstrated by SABINA pediatric data [16]. Airway acidification [17] during asthma attack is not resolved by SABA confirming their poor effect on inflammation that explains why SABA does not prevent subsequent asthma attacks [18]. Notable safety concerns include rare side effects such as vomiting with ipratropium use and the long-term consequences of SABA over-reliance [19, 20]. There is robust evidence against routine SABA use in infants under 12 months with bronchiolitis, since salbutamol shows no clear benefit and may pose harm. Age-specific indications, dosing, and regular monitoring can optimize long-term outcomes of SABA. Hymenoptera venom allergy Hymenoptera venom allergy in children is a significant cause of allergic reactions, ranging from local swelling to potentially life-threatening anaphylaxis that are less common in pediatric populations than in adults. Giovannini et al. [21] review data from several studies and describe the diagnostic approach that typically include a detailed clinical history, skin testing, and measurement of specific IgE, with molecular tests reserved for ambiguous cases. Management of acute reactions follows standard anaphylaxis protocols, with intramuscular epinephrine as the first-line treatment. In selected cases, venom subcutaneous immunotherapy represents a highly effective long-term solution, capable of modifying the natural course of the allergy and preventing recurrence [22, 23] Education on sting avoidance, prompt recognition of symptoms, and appropriate emergency measures are crucial for families. This topic highlights the importance of a structured, evidence-based approach in pediatric allergy care to ensure safety and improve quality of life for affected children [24]. Activated Phosphoinositde 3-kinase syndrome Activated phosphoinositde 3-kinase (PI3Kδ) Syndrome (APDS) is an inborn error of immunity due to gainoffunction mutations in PIK3CD or PIK3R1, leading to aberrant PI3Kδ signaling and clinical manifestations mainly characterized by recurrent infections, lymphoproliferation, autoimmunity, and elevated IgM [25]. Lougaris et al. [26] described characteristics of an Italian cohort (n = 28). Diagnostic latency was significant due to variable age of onset (median ∼ 15.5 years) and phenotypic overlap with other primary immune regulatory disorders. Patients had frequent respiratory infections (∼ 79%), nonclonal lymphoproliferation (∼ 86%), gastrointestinal involvement (∼ 43%), and Ebstein-Barr virusassociated Bcell lymphomas (∼ 14%). Traditional management (immunoglobulin replacement, antimicrobial prophylaxis, and immunosuppressants) was supportive. Hematopoietic stem cell transplantation was the option for severe and refractory cases. mTOR inhibition with sirolimus effectively controls lymphoproliferation but often insufficiently addresses cytopenia [27]. The introduction of selective PI3Kδ inhibitors, particularly Leniolisib, has provided disease-targeted therapy [28]. In Italian population, the use in ∼ 32% of patients, induced improvements in infections, lymphoproliferation, and immune dysregulation. Early genetic testing (e.g., next-generation sequencing) in patients presenting recurrent infections, lymphoproliferation, or hyper-IgM phenotype is essential for a diagnosis which enables prompt initiation of targeted therapy. Overall, integrating heightened diagnostic scrutiny with precision therapy (e.g. leniolisib ± rapamycin or hematopoietic stem cell transplantation) marks a new era in APDS management. Cardiology. 1- Kawasaki disease; 2- postoperative delirium after cardiac surgery; 3- multisystem inflammatory syndrome Kawasaki disease Kawasaki Disease (KD) is a self-limiting prominent vasculitic syndrome affecting children, impacting particularly coronary arteries, leading to aneurysm in severe cases, and it almost represents the major cause of acquire heart diseases. Beside the finding of the precise etiology, still unknow, an important field of research is the mechanism underlying the development of coronary artery lesion. Disorders in the acute phase, of the Glycocalyx of the epithelial and endothelial cells, have shown to be involved in cardiovascular impact of the disease [29–31], with the release in the serum of Syndecan-1, an important transmembrane heparin sulfate proteoglycan with a crucial role vascular endothelial barrier function and inflammatory response modulation [32]. The possibility of assessing circulating endothelial injury biomarkers, such as circulating endothelial cells components, endothelial microparticles may add a diagnostic tool of coronary artery lesions [33]. Challenge in the diagnosis and the management of KD is the early diagnosis of coronary artery lesions, assessing not only their occurrence but also their evolution [34, 35], as far as it correlates with averse late outcomes. Echocardiography remains the primary step for assessing coronary artery lesions in KD, but including ultrasonic, a technology able to detect subtle changes, may aid and speed the process [36]. Kawasaki disease shock syndrome represents a severe manifestation of KD, characterized by hemodynamic instability and multiorgan dysfunction [37]. Diagnosis requires high level of suspicion, and as it can have a dramatic evolution, early diagnosis is crucial to improve the prognosis [38]. Laboratory indicators used to assist the diagnosis lack of specificity and are easy to be interfered by other factors. Predictive models although in specific group may facilitate an early diagnosis [36, 39, 40]. Multisystem inflammatory syndrome Multisystem inflammatory syndrome (MIS-C) in children is a hyperinflammatory syndrome related to Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection with wide area of clinical overlapping with KD [37], particularly regarding the cardiovascular involvement, myocarditis, pericarditis, arrhythmias, coronary artery lesions and aneurysm representing the main cardiovascular complications. Diagnosis and management require close cardiac assessments, and multimodality imaging is increasingly used to assist in this process. Though echocardiography remains the most employed imaging modality it has important limitations [41], limited ability to characterize myocardial tissue abnormalities (oedema, myocardial inflammation and fibrosis), to quantitatively assess cardiac output and valve function, all domains in which magnetic resonance is superior and provides useful complementary information for an accurate diagnosis and prognosis [42]. Postoperative delirium after cardiac surgery Progress in cardiac surgery have significantly modified the story of congenital heart diseases improving the survival rate of children, and though the development of interventional procedure it is still the most important and effective treatment for children with congenital heart diseases, particularly for the complex lesions. It may also bring a series of postoperative complications, with delirium as one of the commonest. Despite its typically transient nature, it is associated with adverse outcomes and known to have a long-term impact on neurocognitive function in adulthood. In children with congenital heart diseases, particularly those with complex lesions, who are high-risk of neurocognitive issues, risk factor investigation for delirium is crucial for the prognosis and outcomes [43, 44]. Critical care. 1- Diquat poisoning; 2- corticosteroid insufficiency Diquat poisoning Diquat is an herbicide used in agriculture. Diquat poisoning is a rare but life-threatening event characterized by rapid systemic toxicity and high mortality. Duan et al. [45]. describe two adolescent cases that underscore how early hemoperfusion (within 4 h) leads to full recovery without permanent damage, whereas delayed intervention results in severe acute kidney injury, encephalopathy, and multi-organ failure, highlighting how rapidly diquat toxicity can escalate. These observations are corroborated by Chen et al. [46] who reported the successful early treatment of a 13-year-old with diquat-induced rhabdomyolysis and shock through prompt fluid resuscitation and hemoperfusion. In contrast, a fatal case in a 17-year-old despite aggressive care emphasizes the narrow therapeutic window and the high risk of mortality [47]. Moreover, Zeng et al. [48] detailed a case series of three children with acute renal tubular necrosis and interstitial inflammation via biopsy who survived with intensive supportive care, including hemoperfusion and steroid–antioxidant therapy. Corticosteroid insufficiency Critical illness-related corticosteroid insufficiency (CIRCI) is a potentially life-threatening dysfunction of the hypothalamic–pituitary–adrenal axis, frequently observed in critically ill pediatric patients, including those with sepsis, trauma, major surgery, and systemic inflammation [49]. Morabito et al. [50] address the ‘hot topic’ of CIRCI in children. CIRCI is characterized by inadequate cortisol production or peripheral glucocorticoid resistance, which exacerbates inflammation and coagulation, leading to increased morbidity, prolonged intensive care unit (ICU) stay, and higher mortality. Its prevalence in pediatric ICUs is poorly defined (estimates span 30–70%), reflecting heterogeneous diagnostic criteria and testing methodologies, including random cortisol or ACTH-stimulation thresholds. The pathogenesis involves reduced CRHstimulated ACTH release, altered cortisol synthesis, decreased cortisol bioavailability, and receptor-level resistance. Diagnostic consensus is lacking pediatric intensivists and endocrinologists disagree on thresholds (baseline/free cortisol, delta cortisol) and test protocols [51]. Therapeutic strategies, often extrapolated from adult guidelines, include low-dose hydrocortisone (e.g., 60 mg/m²/day) or methylprednisolone (1 mg/kg/day in ARDS) for fluid- and vasopressorrefractory shock. However, evidence in children is limited, and there is concern about potential adverse effects—hyperglycemia, immunosuppression, impaired healing, HPA-axis suppression [52]. The authors propose a diagnostic algorithm emphasizing early consideration of CIRCI in persistent shock, tailored testing (random/ACTH-stimulated cortisol), and cautious corticosteroid use with defined indications and close monitoring. They call for larger pediatric-specific studies to validate diagnostic criteria and dosing regimens to optimize benefits and minimize harm. Endocrinology. 1- Diabetic peripheral neuropathy; 2- Hypothyroidism; 3- Cardiovascular risks in obesity; 4- Early adiposity rebound; 5- Gender dysphoria Diabetic peripheral neuropathy Abo Hola et al. [53] has assessed predictors of diabetic peripheral neuropathy (DPN) in 50 children/adolescents, mean age 13.7 years, with type 1 diabetes mellitus versus 50 controls. Diabetic peripheral neuropathy prevalence was 24% via nerve conduction studies [54, 55]. Neuropathic patients showed higher HbA1c, LDL-C, triglycerides, serum neuron-specific enolase, and heat shock protein 27 versus non-neuropathic peers (p < 0.05) [56]. The Michigan Neuropathy Screening Instrument (MNSI) examination score [57] ≥ 1.5 predicted diabetic peripheral neuropathy with 75% sensitivity, 94.7% specificity (AUC = 0.955), while combined MNSI scores improved sensitivity/specificity (91.7%/89.5%). Serum neuron specific enolase outperformed serum heat shock protein (AUC = 0.890 vs. 0.814; 92% vs. 75% sensitivity). Regression identified MNSI and serum neuron-specific enolase as key diabetic peripheral neuropathy predictors. Early diabetic peripheral neuropathy screening using MNSI and serum neuron-specific enolase is recommended, even in asymptomatic youth. Hypothyroidism Sciarroni et al. [58] describe a 19-year-old patient who developed congenital hypothyroidism with goiter due to a homozygous mutation of the SLC26A7, one of the genes responsible for thyroid dyshormogenesis [59]. This is a rare disease of which about twenty cases have been described in the literature [60] and its pathogenesis is still poorly understood. The phenotype of patients is heterogeneous (goiter, for example, appears in approximately half of the cases) and the disease can manifest itself even many years after birth. Furthermore, the specific function of the gene is not known and deserves further studies. Experimental data on an impact of iodide transport [61] have not been fully established and it has been hypothesized that since SLC26A7 is thought to regulate acid–base balance in the renal tubule and gastric epithelium, an analogous function in thyroid follicular cells is possible [60]. Cardiovascular risks in obesity The position paper by Valerio et al. [62] draws attention to the importance of researching, monitoring over time and treating early various cardiovascular risk factors in obese children and adolescents. These factors are primarily linked to insulin resistance and chronic inflammation, which negatively affect endothelial function and increase the risk of developing cardiovascular diseases later in life [63]. Starting from these considerations, lines of research are being developed to define which biological parameters are most predictive for cardiovascular complications using modern machine learning technologies [64] and combining the data obtained with multi-omic approaches on the one hand with the evaluation of the genomic-epigenomic profile on the other to reach an individualized diagnostic-therapeutic approach [65]. Early adiposity rebound Based on a broad and in-depth review of the literature, Li Pomi et al. [66] confirm the importance of preventing early adiposity rebound (EAR), considered as a risk factor for obesity and obesity-related complications in later life. The factors that contribute to EAR are multiple, some non-modifiable such as genetic ones [67], others modifiable both in the pre-natal phase (smoking cessation, maintaining a healthy weight before pregnancy, and achieving appropriate gestational weight gain [68] and in the post-natal phase (correct lifestyles such as physical activity and correct nutrition (breastfeeding). Socio-economic factors that significantly affect the risk of EAR should not be forgotten [69]. Gender dysphoria The position paper on gender dysphoria, promoted by various scientific societies and reported by Calcaterra et al. [70], documents the need to organize and recognize multidisciplinary structures in the healthcare field, coordinated by a central body, to homogeneously address the complex problem of gender dysphoria within a shared political-jurisdictional framework. The widely shared need [71–73] is also emphasized to support scientific research on the use of GnRH analogues to block the development of secondary sexual characteristics and gender-affirming hormonal treatment, id est (i.e.), the therapeutic use of hormones for the purpose of developing secondary sexual characteristics aligned with the affirmed gender. Gastroenterology. 1- functional constipation; 2- irritable bowel syndrome; 3- Gastrointestinal bleeding Functional constipation Functional constipation [74] is a common disorder in the pediatric age, causing abdominal pain and incontinence, clinically diagnosed according to the Rome criteria. Physical activity and diet with fiber and fluid intake is recommended. When non-pharmacological interventions, including education, lifestyle, diet and toilet training, are not sufficient in the management, a pharmacological treatment based on polyethylene glycol is recommended, both for disimpaction and for maintenance treatment [75, 76]. Evidence doesn’t suggest additional diagnostic test unless an organic cause is suspected or treatment fails [76, 77]. Irritable bowel syndrome As well as functional constipation, irritable bowel syndrome [78] is a functional gastrointestinal disorder, whose prevalence has recently increased in childhood. As the disorder is clinically diagnosed according to the Rome criteria, signs and symptoms suggestive for irritable bowel syndrome should be investigated, avoiding additional tests, apart from serology testing for celiac disease and faecal calprotectin and C-reactive protein (CRP), in case of diarrhoea [79]. As for the management, on the base of the literary review, the Italian guidelines [80] suggest either non-pharmacological (diet, psychologic interventions, specific fibres and probiotics) and pharmacological interventions under specialistic supervision [81, 82]. Consensus recommendation [80] includes indication for PEG, rifaximin, antispasmodics, and gut-brain neuromodulators. Gastrointestinal bleeding Gastrointestinal bleeding [83, 84] is a common condition in children, with spontaneous resolution in most of cases, but which requires a systematic approach to achieve optimal outcomes. Clinical signs and symptoms include hematemesis, melena and hematochezia [83]. The priority is the stabilization of the patient’s hemodynamic status, followed by a clinical assessment and appropriate diagnostic procedures [85]. The best pediatric approach [86] should take in consideration patients’ age, suspected site of bleeding and type of bleeding. Infectious diseases 1- Voriconazole; 2- Beta-lactamase; 3- Mycoplasma pneumoniae; 4- Pneumonitis; 5- Over-the-counter antibiotics; 6- Immunization; 7- SARS-CoV-2 and respiratory acute infection Voriconazole In the latest decays, researchers tried to individualize drug treatment in order to optimize benefits and reduce side effects. Voriconazole [87] is a broad-spectrum anti-fungal agent, used for the treatment and for the prevention of invasive fungal infections in high-risk patients. Personalized dosing strategies may ensure efficacy and reduce adverse reactions. Voriconazole plasma concentrations [88, 89] are influenced by genetic and non-genetic factors, including age, concomitant medications, inflammatory status, hepatic and renal functions. The optimal dosing [88, 90] correlates with age in pediatric patients, and younger children usually required higher doses because they exhibit higher concentration levels of voriconazole compared to older children. Beta-lactamase Gram-negative bacilli, which are frequently involved in hospital acquired infections, show resistance to antibiotics with broad-spectrum activity due to extended spectrum β-lactamases [91]. The emergence of antibiotic resistance in these pathogens warrants attention for the proper management of infections. Genetic is involved in this process. The prevalence of the ESBL genotypes varied by geographical region and the time of infection [92–94]. In a study by Elsayed et al. [94] ESBL producers’ isolates were positive by Polymerase Chain Reaction (PCR) for extended spectrum β-lactamases genes, including blaTEM (64%), blaSHV (30%) and CTX-M (22%). Identifying methods that may reduce antimicrobial resistance in hospital acquired infections through the implementation of an antibiotic’s stewardship program and adequate antibiotics surveillance are relevant [94]. Mycoplasma peumoniae Mycoplasma pneumoniae, a causative agent of respiratory infections, may be also responsible for severe extrapulmonary complications including as pleurisy, hydrothorax, plastic bronchitis, thromboembolism, and multiple organ damage [95–98]. Mycoplasma pneumoniae combined with Adenovirus infection is associated with increased expression levels of cytokines [99–101]. IL-6, IL-8, IL-10, IL-17a, LDH, procalcitonin, CRP, and D-dimer can be used as a diagnostic value of different indicators and combined indicators of severe infection [101]. Researchers also speculate that these findings may be used to target therapy to improve prognosis [101, 102]. Prompt recognition and diagnosis are sometimes challenging but they are essential for improving patient outcomes. Treatment in children has become challenging as well. Of note, even if most cases are mild and self-limiting, some patients may develop a severe pneumonia or extrapulmonary complications [103]. These cases may be related to the occurrence of macrolide-resistant germs [104, 105]. The occurrence of Mycoplasma pneumoniae macrolide-resistant may lead to treatment failure, which translates into a longer duration of therapy, persistent cough and increased time to resolution of fever. In case of macrolide-resistant Mycoplasma pneumoniae, patients receiving early oral doxycycline had a shorter duration of fever and hospitalization [106, 107]. Pneumonitis Lung ultrasound has emerged as a safe, accurate, and radiation-free imaging modality for the diagnosis of pediatric pneumonia. A recent meta-analysis demonstrated that lung ultrasound offers superior sensitivity and comparable specificity to chest X-ray, affirming its diagnostic reliability at the bedside [108]. These results are supported by a cross-sectional study, which reported 97.8% sensitivity and 95.2% specificity for lung ultrasound, especially in detecting small consolidations and pleural effusions areas where chest X-ray often falls short. Moreover, lung ultrasound showed excellent concordance with clinical diagnosis and greater accuracy in identifying interstitial patterns [109]. A comprehensive review further validated its diagnostic performance, with pooled sensitivity and specificity of 0.95 and 0.94, and emphasized its use in emergency and resource-limited settings [110]. Consistent with these findings, a recent point-of-care study involving 252 children reported lung ultrasound sensitivity of 99.1% and specificity of 81.5%, both outperforming chest X-ray and confirming its superior overall diagnostic accuracy [111]. An Italian systematic review of literature on pediatric empyema [112], mostly caused by Streptococcus Pneumoniae and Staphylococcus Aureus, was performed to define guideline for the optimal treatment. Searching in PubMed and in Scopus, analyzing literature since 2000 on therapy, the authors concluded that therapy appears lacking solid scientific evidence. In details, reports suggest starting with empirical broad-spectrum antibiotics which can be switched to narrow-spectrum following microbiological exams and eventually antibiotic resistance. As for surgery, the most frequently performed surgical treatment is pleural drainage, while the less performed is open surgery, in case of severe cases [112–115]. As for community-acquired pneumonia, an acute infection of the lung parenchyma acquired outside the hospital or other healthcare settings and typically affecting previously healthy individuals, a recent intersociety consensus [116] provided evidence-based recommendations for the antibiotic treatment in childhood. Analyzing literature from 2012 to 2024, using the Grading of Recommendations Assessment, Development, and Evaluation methods, the final recommendations were obtained through a Delphi consensus of an expert panel. Amoxicillin at 90 mg/kg/day for five days and divided in three doses is the first-line treatment if the child is at least immunized against Haemophilus influenzae type b, while amoxicillin-clavulanate or second- or third generation cephalosporins in case of no/uncomplete immunization [116–118]. Macrolides are proposed in addition to amoxicillin in children over 5 years old, in case of persisting symptoms [116, 119]. Over-the-counter antibiotics Another systemic revision of the literature aimed to assess the use of antibiotics without prescription among children in low –middle income countries [120]. The use of antibiotics even without a medical prescription is a major contributor for antimicrobial resistance and one of the main global public health threat [121–123]. Analysing literature from 2000 to 2024 [120], the prevalence of non-prescription antibiotic use among children in low-and middle-income countries was 38.86%. Penicillin was found as the most frequently antibiotic class used without prescription and upper respiratory infections as the most frequent illness associated to a non-prescribed antibiotic use. Immunization Pediatric immunization is a powerful tool to reduce morbidity and mortality from infectious preventable diseases worldwide as well as to reduce the use of antibiotics and to contrast antibiotic resistance [124, 125]. Nevertheless, incomplete immunization rate still represents a significant burden in low-income countries. Different risk factors may be identified and correlate to incomplete vaccination, including uneducated or unemployed mother, non-antenatal care, non-postnatal care, rural residence, home delivery, having children more than five, non-health insurance [125, 126]. Of note, limited access to healthcare facilities and poor maternal vaccine knowledge in developing countries should be taken in account by policymakers and stakeholders to prioritize enhancing prenatal and postnatal care and immunization awareness [125, 127]. SARS-CoV-2 and respiratory acute infection SARS-CoV-2 infection in most of the pediatric population is mild with a large group presenting mild viral upper respiratory tract infection symptoms or no symptoms at all [128]. Moreover, children tend to recover more quickly than infected adults [129]. Among the pathophysiological mechanisms that may have a role in the milder presentation, Luo et al. [130] underlined the lower expression level of angiotensin-converting enzyme 2 receptor and the weaker binding affinity between angiotensin-converting enzyme 2 receptors and viral spike proteins. Furthermore, the researchers underlined that children have strong pre-activated innate immune response and adaptive immune response, more natural lymphocytes and that they can produce higher levels of IgM, IgG and interferon and lower levels of IL-6 and IL-10 after Sars-Cov-2 infection. Of note, pediatric patients have fewer underlying diseases which may play a role in reducing the risk of a severe disease [130–132]. From the beginning of the CoronaVIrus Disease – 2019 (COVID-19). pandemic, some individuals previously infected with the virus started presenting persistent symptoms, in contrast to those who have not encountered SARS-CoV-2. Consequently, the term “Long COVID” [133] has been introduced to describe the continuation or development of these symptoms for at least two months, occurring three months after the initial SARS-CoV-2 infection, with no other plausible explanation. Initially studied among adults, long COVID demonstrated to represent a significant concern in the pediatric population as well, regardless the variant of the virus and does not exhibit a gender-specific prevalence difference [134]. The most prevalent long COVID symptoms in pediatric patients are weight loss, inappetence, chronic cough, fatigue, sleep disturbances, wheezing, abdominal pain and mood and mental disorders [134, 135]. Several weeks after the acute phase of COVID-19, children may experience the MIS-C presenting with hyperinflammatory shock and features of multisystem involvement at the time of hospital admission [136–139]. Even though many of them require intensive care unit assistance, mortality is low (1%) in high-income countries and significant improvements may be observed rapidly, varying from 6 weeks to 6 months [137, 139–142]. A tempestive diagnosis and a prompt start of treatment are required for recovering [142]. Epidemiological data suggests a reduction in MIS-C after the introduction of SARS-Cov2 immunization as if the vaccine may play a protective role on the onset of MIS-C as well as on its severity [140, 142]. Nevertheless, immunized children may as well develop MIS-C although less frequently and in milder forms [143]. Cases of vaccine-induced MIS, defined in the absence of prior Sars-Cov2 infection, are exceptional in childhood and generally present with milder symptoms [140, 142, 144, 145]. Moreover, COVID 19 infection and restrictive measures influenced the circulation of other pathogens, such as virus, bacteria and fungi. For example, starting from COVID-19 pandemic, an upward trend in Candida infections related to dacryocystitis was noted, suggesting that SARS-COV-2 may influence changes in the infectious flora of dacryocystitis in children [146]. Dacryocystitis is a common ophthalmic disorder in childhood, especially in neonate, related to the persistence of Hasner’s membrane, with quite all cases solving within the first 4 to 6 weeks of life. Congenital disorders of tear duct development leading to dacryocystitis, include unruptured Haner’s valves, blockage of the tear ducts or conjunctivitis due to obstetrical infections, or stenosis of the tear ducts at the bones [146, 147]. If no perforation occurs, the tears gather in the lacrimal duct and sac and may be responsible of infection by several germs, including Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus mitis and Stenotrophomonas maltophilia [147–149]. As well as for bacteria, also the circulation of viruses was affected by SARS-COV-2 infection. As for acute respiratory infections, there was a decline of cases during the lockdown period, likely due to the restrictive measures. Afterwards, the circulation of germs increased again [150, 151]. Nowadays, acute Respiratory Infections still significantly impact children’s health, and place a considerable burden on the Italian National Health Service [152]. An Italian study highlights the substantial burden of acute respiratory infections on pediatric primary care, as evidenced by the high rate of visits, in line with previous reports [153–155]. Of note, an average of 9 follow-up visits per 100 infections were required, with individual visit frequencies varying across specific subtypes. In details, otitis and sinusitis require 12 and 14 visits for 100 episodes; a higher average visit frequency of 55 visits per 100 infections is required in case of pneumonia [153]. Bronchiolitis may cause a significant burden for emergency departments, and paediatric wards and intensive care units due to clinical care requirements, including oxygen supplementation [156]. Respiratory Syncytial Virus (RSV) is the most common cause of acute lower respiratory infections, including bronchiolitis, in the young pediatric population [157–159]. Even if the virus can affect people of all ages, neonates, infants and toddlers under 2 years old experience the heaviest burden in both inpatient and outpatient settings [160, 161]. Epidemiological data reveal that approximately 10% of neonates and children at their first RSV season have to access the emergency department to be then hospitalized, in some cases in intensive care unit [162]. A retrospective study based on the Italian Hospital Discharge Record database evidenced that the mean hospitalization length is 6.3 days, in line with previous reports [163–167]. Despite this information, literature is consistent with gaps in knowledge and lack of risk perception regarding RSV severity, emphasizing the importance of adequate medical education in this area [168–170]. An observational retrospective analysis on administrative databases of healthcare entities revealed that the annual incidence rate of RSV-related hospitalizations was 175–195/100,000 people, with a peak in children aged less than 1 year [171]. In details, literature highlights that younger age ≤ 2 months is associated with a more severe disease and higher hospitalization cost [160, 172]. The economic analysis is consistent with higher direct healthcare costs in RSV patients than in the general population [171]. In the Italian study of Fortunato et al. [172], the mean cost of an RSV-associated hospitalization was 3,036 euros/year, with the higher cost in the 0–2 months age group (4,225 euros/year). Although preterm babies represent a higher risk group for severe disease, most hospitalizations occur in children born at term [171–173]. In Italy, in pre-pandemic era, RSV hospitalization incremented from 125 to 178 per 10,000 infants (+ 42.4%) considering the study period 2015–2019 [163]. In 2020, SARS-CoV-2 pandemic influenced virus circulation, including RSV, due to lockdown and restrictive measures introduced to limit virus spreading [151]. Epidemiological studies indicate that, following the 2020 SARS-CoV-2 pandemic, RSV infections presented with an increased and anticipated peak, requiring hospitalizations in older age groups in the post-pandemic period [174, 175]. An Italian multicenter study reveals a growth of nearly 70% in hospitalisations for bronchiolitis, and an increase in invasive respiratory support and coinfections, suggesting a more severe disease compared to the past [175]. The rise of RSV infection is associated to a rise in other virus circulation which followed the lockdown. Coinfections of RSV and other viruses may be interpreted as the synergic transmission of multiple viruses at once by the same subject who has an immune debt [176, 177]. As well as for virus infection, the post COVID-19 period was characterized as swell by the rise of Group A Streptococcus cases [150]. Despite international guidelines on diagnosis and treatment, the outbreak and recurrence of these cases increased the burden of medical attention in the pediatric age [150, 178–180]. The rate was higher in those aged 3–6 years age, who were mostly characterized by a low score of symptoms, including sore throat, fever, tonsillar exudate, lymphadenopathy and scarlet fever. Symptoms reported in the first and in the following infection were similar, except for fever and scarlet fever which were less frequent in case of recurrence [150]. Surveillance data are useful to predict the hospitalization rate and eventually implement preventive strategies to control the spread of infection [166]. Medical education as well is required as there is a lack of knowledge on RSV, which is likely to affect the use of preventive strategies regardless scientific evidence. An Italian survey pointed out that some physicians lack knowledge on specific monoclonal antibodies and on its demonstrated efficacy in terms of reducing hospitalizations [168]. Opposite to bronchiolitis, there is still a lack of a consensus the definition of recurrent respiratory trait infections in children aged 0–5 years old, which may account up to 25% [181–183]. Furthermore, different from respiratory syncytial virus infection, no specific risk factors had been identified suggesting that they may eventually affect any child regardless of family or clinical history [181, 184]. An Italian study proposed that the diagnosis of recurrent respiratory trait infections may be consistent with at least 4 URTI episodes lasting four days or more within a six-month period and separated from each other by a period of well-being in otherwise well-being children up to 5 years of age [184]. Neonatology. 1- Pulmonary hypertension; 2- Phototherapy; 3- Infant mortality; 4- Human milk; 5- Cord blood transfusions; 6- Vitamin D; 7- Neonatal infections Pulmonary hypertension Maddaloni et al. [185] describe a female neonate presenting with severe, persistent pulmonary hypertension requiring ECMO support on day one [186]. Genetic analysis via Next-Generation Sequencing identified a novel TBX4 heterozygous frameshift mutation (c.1160delC, p.Arg389fsTer27), inherited from an asymptomatic father. The infant improved with intensive therapy but required prolonged pulmonary vasodilators [187]. A literature review (24 cases, 2010–2023) shows 66.7% of TBX4-related PH manifests neonatally, 12% require ECMO, and, in only 20%, associated skeletal abnormalities including the foot and pelvis, patellar aplasia or hypoplasia. De novo mutations account for 46% of cases [188]. Despite the absence of skeletal defects in the reported patient, the findings underscore TBX4’s role in neonatal pulmonary hypertension. The authors recommend including TBX4 in genetic panels for idiopathic neonatal pulmonary hypertension to guide management and genetic counselling. Phototherapy Li et al. [189] evaluated home phototherapy versus inpatient phototherapy for neonatal hyperbilirubinemia [190, 191], synthesizing data from 9 studies (998 neonates; 4 RCTs, 5 cohorts). Home phototherapy was associated with longer treatment duration (SMD = 0.55, P = 0.03) and higher hospital readmission rates (RR = 4.61, P = 0.01). No significant differences were found in daily bilirubin reduction (WMD = − 0.12, P = 0.68), complications (RR = 2.29, P = 0.41), or exchange transfusion (no cases). Home phototherapy significantly reduced parental stress (SMD = − 0.44, P = 0.002). Evidence quality was very low due to bias and heterogeneity. Current data do not strongly support home phototherapy efficacy; large-scale RCTs are needed to assess long-term outcomes and risks comprehensively [192]. Infant mortality The analysis of Italian neonatal, post-neonatal, and infant mortality (2016–2020) [193] reveals persistent geographic and ethnic inequalities [194]. In 2020, neonatal mortality (1.76/1,000 live births) was 55% higher in infants of foreign parents vs. Italian parents. Infant mortality in Southern Italy was ∼ 70% higher than the North for both ethnic groups, with highest rates in Calabria, Sicily, Campania, and Apulia. Poisson regression confirmed elevated mortality risks in the South (e.g., neonatal respiratory distress MRR = 3.01) and among foreign infants (e.g., metabolic disorders MRR = 2.92). During COVID-19’s first wave (March–May 2020), neonatal mortality rose significantly [195, 196], driven by respiratory distress (+ 46%), likely due to disrupted prenatal care. Despite Italy’s low overall infant mortality, profound inequalities necessitate targeted healthcare and social policies. Human milk In a systematic review (PRISMA guidelines), Pagano et al. [197] evaluated long-term (> 24 months) benefits of exclusive human milk diet (breast milk or donor milk) in small for gestational age or intrauterine growth-restricted neonates. After screening 722 records, 9 studies were included. Evidence suggests beneficial effects across four domains: Neurodevelopment (higher IQ/cognitive scores in breastfed small for gestational age infants), Cardiovascular health (reduced ventricular remodeling with prolonged breastfeeding), Somatic growth (human milk during hospitalization improved catch-up growth), and bone mineralization (higher bone density) [198, 199]. However, breastfeeding > 6 months was associated with increased atopic dermatitis risk [200]. The quality of evidence was low due to study heterogeneity, small samples, and variable definitions. Longer follow-up and higher-quality studies are needed to strengthen conclusions for perinatal care guidelines. Cord blood transfusions The interim analysis of the ongoing multicenter BORN RCT [201] that assessed safety and preliminary efficacy of cord red blood cells vs. adult donor red blood cells (A-RBC) transfusions in 58 extremely preterm neonates (24–27 + 6 weeks gestational age) to prevent severe retinopathy of prematurity (ROP) [202, 203] showed interesting results. Cord red blood cells transfusions demonstrated comparable safety to A-RBCs, with similar adverse event rates and post-transfusion biochemistry [204]. Per-protocol analysis suggested reduced severe ROP in infants receiving only CB-RBCs before 30 weeks PMA (0% vs. 40% in A-RBC recipients; RR 1.66, 95% CI 1.06–2.20; p = 0.040). Low HbF levels before 30 weeks PMA predicted severe ROP (p = 0.035). Protocol deviations occurred frequently (39.3% in cord red blood cells arm received A-RBCs). Early exclusive cord red blood cells transfusion may protect against severe ROP, but final analysis of the full cohort (n = 146 planned) is needed. Vitamin D An Egyptian case-control study (90 full-term neonates) [205] investigated vitamin D association with early-onset sepsis [206]. Forty-five newborns with early-onset sepsis (diagnosed within 72 h via clinical/laboratory criteria) were compared to 45 healthy controls. Serum vitamin D levels were significantly lower in the sepsis group (median 15.4 ng/ml vs. 30.4 ng/ml, p < 0.001), with 66.7% deficient (< 20 ng/ml) versus 15.6% in controls. Vitamin D deficiency correlated with longer NICU stays (12 vs. 6.5 days, p = 0.002), higher CRP (median 42 vs. 12 µg/ml, p = 0.01), and severe clinical manifestations (respiratory distress, mottling). A cutoff of < 19.7 ng/ml predicted sepsis (AUC 0.76; 84.4% sensitivity). Adjusted analysis confirmed vitamin D deficiency independently increased sepsis risk 4.5-fold (p < 0.001) [207]. Maternal vitamin D supplementation during pregnancy may reduce EOS risk in term neonates [208]. Neonatal infections A retrospective study (2020–2022) [209] analyzed 2,109 pregnant women to evaluate Group B Streptococcus colonization rates, intrapartum antibiotic prophylaxis (IAP) adherence, and neonatal outcomes during/after the COVID-19 pandemic [210, 211] Group B Streptococcus screening was performed in 73.92% of participants, with 11.42% colonization. Only 21.48% of at-risk mothers received adequate IAP, while 70.8% received none/incomplete prophylaxis despite indications. Early-onset disease occurred in 13 neonates (6.06/1,000), all born to mothers without adequate IAP. Screening rates were higher during the pandemic (75.65% vs. 70.38%, p = 0.009), but IAP adequacy and Early-onset disease incidence (8.06% vs. 5.45%, p = 0.53) showed no significant differences between pandemic and post-pandemic periods. Suboptimal IAP implementation persisted, driving preventable Early-onset disease cases. Findings underscore the need for improved obstetric-neonatological collaboration and protocol adherence to reduce Group B Streptococcus -related morbidity [212]. Parvovirus B19 causes various clinical manifestations in children [213], that range from common benign fifth disease to severe complications such as transient aplastic crisis in children with hemolytic anemias, arthralgia/arthritis, myocarditis, and neurological disorders [214]. Immunocompromised and transplant recipients are at a higher risk for persistent or atypical disease [215]. In pregnancy, fetal transmission (9–20 weeks gestation) risks include hydrops fetalis and miscarriage, managed via intrauterine transfusion [216]. No specific antiviral therapy or vaccine exists. Treatment is supportive (analgesics, transfusions) or targeted (IV immunoglobulins for persistent infection/immunodeficiency; corticosteroids for myocarditis/joint inflammation). Early recognition of severe manifestations, particularly hematologic, cardiac, and fetal involvement, is critical to guide intervention and improve outcomes. Ongoing research aims to develop targeted antivirals and vaccines. A report by Jia et al. [217] that examined influenza burden, highlighted that neonatal influenza spreads mainly through contact with family members affected by mild respiratory symptoms [217, 218]. Regardless the unspecific clinical manifestations of neonatal influenza which may just be characterized by fever, a prompt identification and therapy is required [217–219]. Nephrology. 1- down syndrome; 2- Wilms tumor; 3- nephrotic syndrome Down syndrome A meta-analysis (8 articles, ∼ 18,000 Down syndrome (DS) subjects) [220], reveals significantly elevated risks of kidney/urogenital abnormalities and lower urinary tract dysfunction in DS versus controls [221, 222]. The authors report a 5.49-fold higher risk (95% CI: 1.78–16.93) of kidney/urogenital malformations (penile anomalies, obstructive defects, dilated tracts, hypodysplasia) with prevalence 0.63%. Undescended testes were 31 times more common (6.2% vs. 0.2%). There was a 2.95-fold higher risk (95% CI: 1.15–7.56) of lower urinary tract dysfunction (incontinence, frequency) with a prevalence of 50.4%. Reduced kidney size (69% of control weight) was confirmed via autopsy and US studies. These findings highlight the need for vigilant screening in DS, including genital exams, urinary symptom assessment, and renal ultrasound [223]. Proactive management may mitigate complications like infections or chronic kidney disease. Wilms tumor A longitudinal cohort study [224] analyzed 2,273 Wilms tumor patients from the SEER*Stat Database (2000–2019) [225]. Overall survival rates were 93.6% (5-year) and 92.5% (10-year). Renal cancer was the primary cause of death (77.3%). Relative survival rates were 98.10% (1-year), 92.80% (5-year), and 91.3% (10-year). Conditional survival improved with time post-diagnosis (e.g., 94.0% at 1 year vs. 99.0% at 10 years for subsequent 5-year survival). Multivariate analysis identified tumor stage as the strongest prognostic factor: distant spread (aHR 9.22), regional spread (aHR 2.84), and unknown stage (aHR 4.98) significantly worsened cancer-specific survival versus localized tumors. Age, sex, chemotherapy, laterality, and race did not independently impact survival. Findings emphasize stage-based risk stratification for personalized WT management [226, 227]. Nephrotic syndrome A novel biallelic variants in NUP93, NUP107, and NUP160 genes [228] causing severe steroid-resistant nephrotic syndrome (SRNS) has been identified in four Chinese children [229]. All patients were female, presented with SRNS (median onset age: 5.08 years), and showed rapid progression: three reached end-stage kidney disease (ESKD; median age 7 years), and one developed stage 3 chronic kidney disease. Kidney biopsies revealed focal segmental glomerulosclerosis (FSGS) in three patients. Whole-exome sequencing detected five missense variants, one nonsense variant, one frameshift variant, and one splicing variant across the genes—all previously unreported. Extrarenal manifestations included heart failure, intellectual disability, and uterine dysplasia. These findings expand the mutational spectrum of nucleoporin genes in SRNS and underscore the critical role of next-generation sequencing for diagnosis and guiding management in genetically mediated SRNS [230, 231]. In a multi-center retrospective study, Li et al. [232] analyzed 279 children with steroid-resistant nephrotic syndrome (SRNS) from Guangxi, China [233]. The authors report a male predominance (70.3%), with median onset age 54 months. Initial SRNS in 65.2%, and secondary SRNS in 33.0%, who showed significantly better response to immunosuppressants (77.2% vs. 54.9%, P < 0.001) and lower stage 5 chronic kidney disease progression (1.1% vs. 6.6%) than Initial SRNS. Major complications were hypertension (18.6%), vitamin D deficiency (20.4%), acute kidney injury (8.6%) [234]. An Effective immunosuppressant therapy reduced chronic kidney disease risk (HR = 0.168, P = 0.036) [235]. Acute kidney injury was an independent risk. Most common pathology was minimal change disease (26.5%) and focal segmental glomerulosclerosis (22.9%). Neurology and neuropsychiatry. 1- School behaviour; 2- Anorexia nervosa; 3- Paternal caregiving; 4- Autism; 5- epilepsy and seizures; 6- eating skills; 7- Autoimmune encephalitis; 8- Cerebral palsy; 9- Hippotherapy; 10- Plagiocephaly School behaviour Di Vincenzo et al. [236] reviewed ten studies on school refusal behavior (SRB) in children and adolescents over a five-year period, focusing on its clinical significance and association with psychopathological profiles [237, 238]. School refusal behavior is linked to neurodevelopmental disorders (e.g., autism, Attention Deficit Hyperactivity Disorder (ADHD) and psychiatric conditions (e.g., anxiety, depression), as well as risk factors like low self-concept, cyberbullying, and excessive internet use. Environmental and familial stressors, such as maltreatment and parental mental illness, further exacerbate school refusal behavior [238]. The review highlights the heterogeneity of school refusal behavior and emphasizes the need for tailored interventions, including cognitive-behavioral therapy and school-based programs, to address underlying emotional and social challenges. Early identification and multidisciplinary approaches are crucial for improving outcomes [239]. Limitations include geographic bias and variability in study designs, underscoring the need for further cross-cultural research. Anorexia nervosa Marchili et al. [240] analyzed the costs of hospitalization in the acute phase of 260 pediatric anorexia nervosa (AN) patients (aged 6–18 years) at Bambino Gesù Children Hospital (March 2019 - October 2022). The total hospitalization cost was €3,352,333, with a median cost per admission of €11,124 and median daily cost of €593. Significant factors increasing length of stay and cost included comorbidities (24.2% of patients), need for enteral feeding (EF, 43.1%), and requirement for 1:1 monitoring (guarded patients, 4.2%) [241]. Comparing pre-COVID-19 (subgroup A) and post-onset (subgroup B), subgroup B had significantly more admissions (224 vs. 36) but shorter median length of stay (18 vs. 29 days) and lower median cost (€10,695 vs. €16,758). This shorter length of stay correlated with earlier initiation of enteral feeding post-COVID-19 onset (3 vs. 8 days). The study highlights the substantial economic burden of pediatric anorexia nervosa and the pandemic’s influence on hospitalization patterns [242, 243]. The Italian Pediatric Society Adolescent Study Group [244] identified early detection strategies [245] for pediatric anorexia nervosa. The authors analyzing 52 studies (from 657 screened via PRISMA guidelines), focused on relevant key themes: red flags/screening (23 studies), genetics (12), neurological pathways (11), environment (10), and gut microbiota (7). Critical red flags include body dissatisfaction, restrictive eating, compensatory behaviors, unexplained growth delay, comorbid psychiatric conditions (97% of hospitalized patients), and autoimmune comorbidities (37% increased risk). Environmental triggers encompass bullying, social media, COVID-19 stressors, and childhood trauma [246]. Genetic predisposition and gut dysbiosis were significant biological factors. The review synthesizes these findings in a useful screening tool for pediatricians and child neuropsychiatrists, emphasizing multidisciplinary assessment during routine checkups, including psychological evaluation, growth monitoring, and physical examination, to enable early intervention [247]. Bozzola et al. [248] investigates the association between photo manipulation and anorexia nervosa risk in children/adolescents [249, 250]. Screening 98 PubMed records via PRISMA guidelines identified two relevant Australian studies. Both studies found important key points; (1) Adolescent girls regularly sharing edited selfies reported significantly higher body dissatisfaction, weight/shape overvaluation, dietary restraint, and thin-ideal internalization (2) Appearance-focused social media behaviors correlated with eating disorder symptoms in adolescents, with notable risk among males. Unrealistic beauty standards perpetuated by photo editing tools may heighten body dissatisfaction in vulnerable youth. The Italian Pediatric Society Communication Group suggests reducing risks: studies on photo manipulation’s psychological impact, social awareness campaigns, school-based digital literacy programs, and integrating technology-use discussions into routine pediatric visits, especially during pre-adolescence [251]. Paternal caregiving Sari et al. [252] examined how paternal childcare involvement and screen habits influence early childhood development (ECD) in 464 Turkish fathers of children aged 24–60 months [253]. Using online surveys, researchers assessed father-child interactions, media usage, and ECD outcomes via the ECD Index (ECDI). Results showed 89.7% of children were developmentally on-track. Key predictors included higher paternal education, later screen introduction, child engagement in alternative activities (vs. tantrums) when denied screens, and access to ≥ 3 books. Girls and older children (4 years) also showed better outcomes. Both child and father screen time, adequate childcare, and literacy-numeracy skills correlated positively with adaptive child behavior during screen restrictions [254]. The findings underscore the need for father-focused ECD interventions addressing media habits, promoting quality caregiving, and learning resources [255]. Autism A meta-analysis [256] evaluated the efficacy of probiotics in treating autism spectrum disorder symptoms and gastrointestinal issues in children [257]. Six randomized controlled trials were analyzed. Probiotics did not significantly improve core autism spectrum disorder symptoms, as measured by scales including Aberrant Behavior Checklist, Social Responsiveness Scale, Child Behavior Checklist, Clinical Global Impression Improvement and developmental quotients. However, probiotics significantly reduced gastrointestinal symptom severity (6-GSI: MD = 0.59, 95%CI [-1.02, -0.17], P = 0.006). Heterogeneity arose from variable probiotic strains, treatment durations, and geographical differences [258]. While probiotics alleviate gastrointestinal comorbidities in autism spectrum disorder children, they show no measurable benefit for behavioral or neurodevelopmental symptoms [259]. Further high-quality RCTs are needed to clarify optimal strains and treatment protocols. Epilepsy and seizures Zuo et al. [260] analyzed etiologies in 167 children with drug-resistant epilepsy. Etiology was identified in 53.3%: structural (23.4%), genetic (19.2%), multiple factors (7.2%), and immunological (3.6%). Genetic causes presented earliest (median onset: 0.46 years), significantly younger than structural (3 years; P < 0.001) or immunological causes (4.5 years; P = 0.001). Ion channel genes (e.g., SCN1A, KCNQ2) dominated genetic cases (52.3%). Structural causes included congenital malformations (35.9%) and acquired injuries (64.1%). Epilepsy syndromes occurred in 35.9%, predominantly in infants. Over 46% of cases had unknown etiology, partly due to incomplete genetic testing. Findings underscore genetic testing’s value in early-onset drug-resistant epilepsy and highlight etiology-specific management as surgery for structural pathologies [261–263]. Febrile seizures (FS) are common, typically benign convulsions provoked by fever in children aged 6 months to 5 years, affecting 2–9% of children [264]. They are classified as simple (generalized, < 15 min, no recurrence in 24 h) or complex (focal features, > 15 min, or recurrence). Most terminate spontaneously; seizures > 5 min require benzodiazepine rescue. The diagnostic workup includes identification of the fever source; routine tests (EEG, neuroimaging, LP) considered unnecessary for simple FS in well-appearing children [265]. Hospitalization is advised for complex FS, young age (< 18mo), or concerning signs [266, 267]. Recurrence risk (30–50%) is higher with young age, family history, or low fever at seizure onset; epilepsy risk is low (1%) overall but increases with complex features. Antipyretics prevent fever discomfort but not FS. Chronic anti-seizure prophylaxis is not recommended. Family counseling is crucial to alleviate anxiety and provide seizure first-aid guidance [267]. Eating skills The progressive functional maturation and coordination of eating skills has been described by Kalhoff et al. [268]. Swallowing begins prenatally at 13 weeks gestation, involving Central Pattern Generators, postnatally evolving from milk feeding (requiring swallowing-breathing coordination) to spoon-fed purees (dependent on head/jaw control) and finally self-feeding finger foods (fine motor skills). Milestones align with gross motor development and psychosocial individuation. Disruptions in neuromotor development, sensory processing, or organic conditions can cause dysphagia, affecting ∼ 25% of young children and up to 90% in neuromuscular disorders [269]. Dysphagia jeopardizes nutrition and growth, necessitating early multidisciplinary management for safe swallowing and autonomous eating [270, 271]. The German dietary schedule’s phased introduction of complementary foods accommodates individual developmental variability. Early eating competence supports long-term healthy eating patterns. Autoimmune encephalitis Liao et al. [272] characterizes contacting-associated protein-2 (CASPR2) antibody-associated autoimmune encephalitis in children through retrospective analysis of 125 pediatric autoimmune encephalitis patients [273]. Among them, after anti-NMDAR, CASPR2-IgG was the second most common neuronal surface antibody (3.2%, 4 patients) [273, 274]. Median onset age was 5.6 years. Predominant symptoms included psychiatric/behavioral abnormalities (75%) and sleep dysfunction (75%). One patient developed Rasmussen encephalitis phenotype. No tumor was detected. Initial brain magnetic resonance was abnormal in 50% of cases. All patients responded to first-line immunotherapy (intravenous steroids/immune globulins), with one relapse case requiring surgery. At follow-up (33–58 months), all achieved favorable outcomes by the modified Rankin Scale (mRS ≤ 1). CASPR2 autoimmunity represents a significant pediatric autoimmune encephalitis subtype with distinct clinical features and excellent long-term prognosis [275]. Cerebral palsy Wang et al. [276] reported global research trends in spastic cerebral palsy from 2000 to 2022 using 3,988 publications from Web of Science [277]. The United States led in productivity (1,062 publications), followed by the Netherlands and Australia. Key institutions included Katholieke Universiteit Leuven and Vrije Universiteit Amsterdam. Developmental Medicine and Child Neurology was the top journal. Research evolved through three phases: initial low output (2000–2005), steady growth (2006–2015), and rapid expansion post-2016. Keyword analysis identified major clusters: reliability, gait analysis, management, and botulinum toxin. Burst detection revealed shifting hotspots: early focus on clinical trials and periventricular leukomalacia transitioned to randomized controlled trials, definition standardization, and muscle morphology. The study highlights increasing research interest and emerging directions in spastic cerebral palsy, emphasizing efficacy evaluation and novel interventions [278, 279]. Hippotherapy Hippotherapy is worldwide used [280]. A systematic review evaluates hippotherapy’s effects on motor function in children with cerebral palsy, analyzing 10 studies (2015–2023) [281]. Findings demonstrate consistent improvements in gross motor skills, balance, coordination, gait parameters, and muscle strength across children aged 2–14 years, regardless of Gross Motor Function Classification System level. Two studies using a Horse-Riding Simulator reported enhanced postural control in sitting, motor function, and hip abduction range of motion. Reductions in hip adductor spasticity were also observed. Sessions typically involved 30–45 min of therapy 1–3 times weekly for 8–20 weeks. Hippotherapy shows benefits as both standalone treatment and adjunct to conventional therapies, positively impacting functional independence and quality of life [282]. Further research is needed to assess long-term outcomes and compare Horse-Riding Simulator efficacy with live hippotherapy [283]. Plagiocephaly Panza et al. [284] showed efficacy of osteopathic treatment for positional plagiocephaly and brachycephaly in 424 infants (91.98% plagiocephaly; 8.02% brachycephaly). Infants received a median of 3 osteopathic sessions (IQR: 3–4), focusing on cranial membrane/suture normalization and cervical/thoracic alignment [285, 286]. Both groups showed complete resolution of cranial deformities post-treatment. Higher severity scores (median: 3) were more common in preterm infants (p = 0.021) and males (p = 0.039). Treatment sessions required correlated directly with severity (p < 0.001) but not gender/prematurity. Significant improvement occurred within five sessions in early infancy, preventing neurodevelopmental complications. Authors suggested osteopathy as a first-line, non-invasive treatment for positional cranial deformities when preventive measures fail [287]. Nutrition. 1- gender; 2- triheptanoin Gender Sex and gender differences play a role in pediatric nutrition and related pathologies [288]. Biological factors (body composition, hormone-driven fat distribution) and sociocultural influences (dietary patterns, body image) create distinct nutritional needs and health outcomes [289, 290]. Females exhibit healthier diets but higher eating disorder risk; males show preference for calorie-dense foods and android obesity linked to metabolic complications. Disease disparities include higher metabolic dysfunction-associated steatotic liver disease prevalence in males; female predominance in celiac disease and anemia; inflammatory bowel disease variations in genetics, phenotype, and treatment response [291]. Sex-specific dietary reference values for energy, protein, vitamins, and minerals are outlined. Triheptanoin Longchain fatty acid oxidation disorders are rare and lifethreatening diseases responsible of energetic deficit and accumulation of toxic metabolites. Triheptanoin [292] was more helpful than MCT oil in 9 patients with long chain fatty acid oxidation disorders [293]. Triheptanoin (1.5 g/kg/day) significantly reduced intercurrent catabolic episodes (4.3 vs. 22.0, p = 0.034) and metabolic decompensations requiring hospitalization (2.0 vs. 18.3, p = 0.014) compared to prior MCT therapy [294]. Annualized hospitalization rates (0.7 vs. 3.1/year, p = 0.03) and duration (3.6 vs. 10.5 days, p = 0.004) also decreased. Mean creatine kinase levels (during/outside decompensation) trended lower with triheptanoin. No intensive care unit admissions occurred during triheptanoin treatment. Gastrointestinal side effects (epigastric pain, diarrhea) were mild and similar between treatments. Triheptanoin demonstrated superior efficacy in reducing acute events and hospitalizations [295]. Palliative care. 1- service in italy; 2- caregivers Services in Italy Estimation of the specialized pediatric palliative care (PPC) burden and their diffusion and quality in Italy represent urgent needs to ensure a better coverage and quality of services [296]. The Italian PalliPed study [297] evaluated PPC services across 19 centers in 12 regions. Key findings reveal significant gaps: 7 regions (mainly central-southern Italy) lack PPC facilities. Only 15% of estimated PPC was made (1,092 patients vs. ∼10,600 estimated). Few referral centers offer full regional coverage (45%) or 24/7 service (27%). Staffing is inadequate and aging; 77% of nurses lack PPC training. Patient numbers increased (1,202 in 2019 to 1,544 in 2021), but resources remain insufficient. Urgent needs include staff training, resource reorganization, and standardized national strategies to address evolving patient needs and ensure equitable access [298, 299]. Caregivers A survey [300] investigated the role and challenges faced by caregivers [301] managing medication for PPC patients at a specialized center in Padova, Italy (n = 100 caregivers). Most caregivers were mothers (91%). Key findings include high polypharmacy prevalence (67% of patients), frequent daily preparation demands (52% prepared medications ≥ 3 times/day), and significant time burden (32% took > 5 min/preparation). Only 59% reported formal medication management training. Alarmingly, 14% reported recent administration errors, primarily attributed to tiredness (35.7%) and regimen complexity (28.6%). Many caregivers perceived excessive medication use (41%), yet 73% welcomed pharmacist-led counseling [302]. The study concludes that simplifying regimens, optimizing formulations, enhancing caregiver training, and integrating clinical pharmacists are crucial strategies to reduce errors and alleviate caregiver burden in PPC [303]. Respiratory tract illnesses. 1- breath holding spell; 2- plastic bronchitis Breath holding spell Given the increasing reliance of parents on online platforms for pediatric health information, evaluating the quality of such content is critical. For this reason, Demirtas et al. assessed 55 English-language YouTube videos using the mDISCERN and Global Quality Scores, finding that videos produced by medical professionals and academic institutions were significantly more reliable and informative. Most high-quality videos originated from expert sources, whereas content from independent creators was often misleading or of low quality [304]. This trend is consistent across other pediatric health domains. For example, a study on asthma inhaler technique found that only videos produced by healthcare professionals correctly demonstrated proper usage [305]. Similarly, an analysis of YouTube content about Behçet’s disease showed that professional-uploaded videos had significantly higher DISCERN and GQS scores compared to non-professional ones [306]. A review on spasticity reached the same conclusion, confirming the greater trustworthiness of expert-generated content [307]. Plastic bronchitis Plastic bronchitis is a rare but severe complication following congenital heart surgery, particularly in children with Fontan physiology or airway anomalies [308, 309]. In a retrospective cohort study [310] of 68 postCHS pediatric patients (May 2016–Oct 2021), two phenotypic groups were identified: those with airway abnormalities (n = 32) and those with right ventricular dysfunction (n = 36). All patients underwent therapeutic fiberoptic bronchoscopy for cast removal and diagnostic evaluation, with pathogens detected in bronchoalveolar lavage fluid in 41 cases (32 airway group, 9 right ventricular dysfunction). Primary treatment strategies included antibiotics, systemic corticosteroids, and inhaled budesonide; those with right ventricular dysfunction also received targeted therapy to reduce pulmonary arterial pressure [311]. Clinical improvement was observed in 64 patients, with only two requiring veno-arterial extracorporeal membrane oxygenation due to recurrent plastic bronchitis (and respiratory failure. The authors emphasize the essential role of bronchoscopy both for cast clearance and definitive diagnosis, alongside pharmacotherapy aimed at infection control, inflammation mitigation, and hemodynamic optimization. They conclude that early recognition in at-risk children (airway anomalies or right ventricular dysfunction post congenital heart surgery, prompt bronchoscopy, and comprehensive treatment are key to improving outcomes—and veno-arterial extracorporeal membrane oxygenation remains a critical salvage option in refractory cases. Social media. 1- health professional; 2- Sharenting Health professional Social media increased either in the number of users and in the time spent on devices. As for Italy, 44.4 million people use social media monthly, a number expected to increase up to 47.6 million users in the next years [312]. Platforms including Facebook, Instagram, and TikTok are much used and are growing their role as major source of information for health professionals, patients, and caregivers [313–317]. Despite the potential of diffusing sanitary information, concerns are rising about misinformation and about the reliability of information on social media due to the prevalence of non-evidence-based and scientifically unproved contents [314, 318]. Due to the challenges of digital health communication in pediatrics, a network of pediatricians can be useful as a safeguard against misinformation in digital information [314]. Sharenting It is important to inform caregivers about the risks related to sharenting, the increasingly popular habit of parents to share photos, videos, or other information regarding their children on their social profiles, through online platforms [319, 320]. Sharenting can expose children to numerous risks including legal aspects linked to child image protection, data privacy and digital security [320, 321]. Consequences include as well the risk of spreading content that can be used as material on pedophilia networks [322, 323]. Parents share multimedia contents with positive intentions and without the perception of the risks [324, 325]. A survey on over four hundred parents with children aged between 0 and 16 years highlights that the content shared are on significant events such as birth or birthdays or child’s artistic activities [319]. Through image sharing, especially when personal information and the child’s face are present, a child’s digital identity is created, even without the consent of the minor [316, 326, 327]. An Italian survey on two hundred twenty-eight parents of children under 18 years of age revealed that most of families are unaware of the current legislation and of the risks related to the practice of sharenting [320]. As a consequence, it is important to increase parental awareness on the risks of sharenting and to educate them in using social media prudently. Scientific societies as well as pediatricians’ network may educate parents through digital and print resources [324]. Conclusions The field of pediatrics has seen several key advances in the past year. Key advances encompassed breakthroughs in pathogenic mechanisms, improved diagnostic accuracy, personalized interventions, and progress in basic and translational research on disease progression. Interesting and promising novelties on prevention have been reported. Lastly, findings shed light on the current management of diseases and outline potential future directions. We think that published papers may potentially could exert a significant short- and long-term influence on healthcare practice.